St. Jude granted European approval for new lead delivery system
May 27, 2010 by MedCity News
St. Jude Medical wins CE Mark approval to begin selling and marketing the latest version of its Epiducer lead delivery system.
St. Jude Medical (NYSE:STJ) has received European regulatory approval to begin selling the next-generation version of its Epiducer lead delivery system.
Leads are wires containing electrodes that deliver electrical shocks from neurostimulators, which use electricity to block the transmission of pain signals to the brain in patients suffering from chronic pain.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
Navigation
NEWS
Abbott touts CE Mark for "world's longest" coronary DES
Illinois healthcare giant Abbott lands European regulatory approval for the Xience Xpedition 48,...
ALung pursues Chinese approval for Hemolung
ALung Technologies says it's going for a Chinese regulatory nod for its Hemolung respiratory assist...
Legal: Patient's lawyer says Intuitive Surgical's training is all about "control"
An attorney for a plaintiff suing robot-assisted surgical systems maker Intuitive Surgical says the...
Can a smartphone help spot a stroke? | MassDevice.com On Call
The American Stroke Assn. and partners release the Spot a Stroke F.A.S.T. smartphone app to help...
Chest docs include Covidien's superDimension lung biopsy device in guidelines
The lung biopsy device acquired by Covidien in its superDimension acquisition is included in new...
